Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Common Krait long-chain three-finger alpha-neurotoxins are a class of potent neurotoxic proteins found in the venom of the snake Bungarus caeruleus [PubMed: 30219148]. These toxins belong to the three-finger toxin (3FTx) superfamily, characterized by a structural motif of three beta-stranded loops extending from a central core [UniProt: Family: Three-finger toxin family]. Their primary biological function is to act as high-affinity antagonists of the nicotinic acetylcholine receptors (nAChRs) located at the postsynaptic membrane of the neuromuscular junction [PubMed: 15649515]. By binding to these receptors, the toxins prevent the neurotransmitter acetylcholine from initiating muscle contraction, leading to progressive flaccid paralysis [WHO: Snakebite envenoming]. In clinical cases of envenomation, this paralysis often results in fatal respiratory failure if not treated promptly with appropriate antivenom [PubMed: 25463111]. These toxins are the primary targets for neutralization by polyvalent and monovalent antivenoms, which contain antibodies that bind and sequester the toxins [StatPearls: Snake Toxicity]. Additionally, they are widely used in pharmacological research as molecular probes to study the structure and function of acetylcholine receptors [PubMed: 11744018].
Neutralization of the toxin by antibody binding, which prevents the toxin from interacting with nicotinic acetylcholine receptors at the neuromuscular junction.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-neurotoxin (Bungarus caeruleus) (α-NTX).